Text Size

Infection Surveillance in Intensive Care Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Herlev Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Herlev Hospital
ClinicalTrials.gov Identifier:
NCT00197847
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.

As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.


Condition
Infection
Pneumonia
Sepsis
Cross Infection

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Pneumonia Sepsis
U.S. FDA Resources

Further study details as provided by Herlev Hospital:

Estimated Enrollment: 549
Study Start Date: December 2002
Estimated Study Completion Date: September 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:Admission to ICU -

Exclusion Criteria:Absence of informed consent and age less than 18 years

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00197847

Locations
Denmark
Department of Intensive Care
Copenhagen, Copenhagen Couty, Denmark, DK-2730
Sponsors and Collaborators
Herlev Hospital
Investigators
Principal Investigator: Dorthe H Olsen, M.D. Department of Intensive Care, Herlev University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00197847     History of Changes
Other Study ID Numbers: KA 02071
Study First Received: September 12, 2005
Last Updated: September 12, 2005
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Cross Infection
Pneumonia
Sepsis
Infection
Lung Diseases
 Respiratory Tract Diseases
Respiratory Tract Infections
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes

ClinicalTrials.gov processed this record on October 16, 2012